We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Ahead of Addus HomeCare (ADUS) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Read MoreHide Full Article
The upcoming report from Addus HomeCare (ADUS - Free Report) is expected to reveal quarterly earnings of $1.38 per share, indicating an increase of 4.6% compared to the year-ago period. Analysts forecast revenues of $292.16 million, representing an increase of 5.7% year over year.
The current level reflects an upward revision of 0.6% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
Given this perspective, it's time to examine the average forecasts of specific Addus HomeCare metrics that are routinely monitored and predicted by Wall Street analysts.
According to the collective judgment of analysts, 'Revenue- Personal care' should come in at $203.82 million. The estimate indicates a year-over-year change of -0.3%.
It is projected by analysts that the 'Revenue- Home Health' will reach $17.29 million. The estimate suggests a change of +1% year over year.
Analysts predict that the 'Revenue- Hospice' will reach $58.01 million. The estimate indicates a year-over-year change of +6%.
Shares of Addus HomeCare have experienced a change of -15.4% in the past month compared to the +4.7% move of the Zacks S&P 500 composite. With a Zacks Rank #2 (Buy), ADUS is expected to outperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Ahead of Addus HomeCare (ADUS) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
The upcoming report from Addus HomeCare (ADUS - Free Report) is expected to reveal quarterly earnings of $1.38 per share, indicating an increase of 4.6% compared to the year-ago period. Analysts forecast revenues of $292.16 million, representing an increase of 5.7% year over year.
The current level reflects an upward revision of 0.6% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
Given this perspective, it's time to examine the average forecasts of specific Addus HomeCare metrics that are routinely monitored and predicted by Wall Street analysts.
According to the collective judgment of analysts, 'Revenue- Personal care' should come in at $203.82 million. The estimate indicates a year-over-year change of -0.3%.
It is projected by analysts that the 'Revenue- Home Health' will reach $17.29 million. The estimate suggests a change of +1% year over year.
Analysts predict that the 'Revenue- Hospice' will reach $58.01 million. The estimate indicates a year-over-year change of +6%.
View all Key Company Metrics for Addus HomeCare here>>>
Shares of Addus HomeCare have experienced a change of -15.4% in the past month compared to the +4.7% move of the Zacks S&P 500 composite. With a Zacks Rank #2 (Buy), ADUS is expected to outperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>